Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Apr 1;101(7):1468–1478. doi: 10.1172/JCI1122

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

L Liaw 1, D E Birk 1, C B Ballas 1, J S Whitsitt 1, J M Davidson 1, B L Hogan 1
PMCID: PMC508725  PMID: 9525990

Abstract

Osteopontin (OPN) is an arginine-glycine-aspartate (RGD)- containing glycoprotein encoded by the gene secreted phosphoprotein 1 (spp1). spp1 is expressed during embryogenesis, wound healing, and tumorigenesis; however, its in vivo functions are not well understood. Therefore, OPN null mutant mice were generated by targeted mutagenesis in embryonic stem cells. In OPN mutant mice, embryogenesis occurred normally, and mice were fertile. Since OPN shares receptors with vitronectin (VN), we tested for compensation by creating mice lacking both OPN and VN. The double mutants were also viable, suggesting that other RGD-containing ligands replace the embryonic loss of both proteins. We tested the healing of OPN mutants after skin incisions, where spp1 was upregulated as early as 6 h after wounding. Although the tensile properties of the wounds were unchanged, ultrastructural analysis showed a significantly decreased level of debridement, greater disorganization of matrix, and an alteration of collagen fibrillogenesis leading to small diameter collagen fibrils in the OPN mutant mice. These data indicate a role for OPN in tissue remodeling in vivo, and suggest physiological functions during matrix reorganization after injury.

Full Text

The Full Text of this article is available as a PDF (3.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birk D. E., Mayne R. Localization of collagen types I, III and V during tendon development. Changes in collagen types I and III are correlated with changes in fibril diameter. Eur J Cell Biol. 1997 Apr;72(4):352–361. [PubMed] [Google Scholar]
  2. Birk D. E., Nurminskaya M. V., Zycband E. I. Collagen fibrillogenesis in situ: fibril segments undergo post-depositional modifications resulting in linear and lateral growth during matrix development. Dev Dyn. 1995 Mar;202(3):229–243. doi: 10.1002/aja.1002020303. [DOI] [PubMed] [Google Scholar]
  3. Birk D. E., Trelstad R. L. Extracellular compartments in matrix morphogenesis: collagen fibril, bundle, and lamellar formation by corneal fibroblasts. J Cell Biol. 1984 Dec;99(6):2024–2033. doi: 10.1083/jcb.99.6.2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Birk D. E., Zycband E. I., Woodruff S., Winkelmann D. A., Trelstad R. L. Collagen fibrillogenesis in situ: fibril segments become long fibrils as the developing tendon matures. Dev Dyn. 1997 Mar;208(3):291–298. doi: 10.1002/(SICI)1097-0177(199703)208:3<291::AID-AJA1>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  5. Brown L. F., Papadopoulos-Sergiou A., Berse B., Manseau E. J., Tognazzi K., Perruzzi C. A., Dvorak H. F., Senger D. R. Osteopontin expression and distribution in human carcinomas. Am J Pathol. 1994 Sep;145(3):610–623. [PMC free article] [PubMed] [Google Scholar]
  6. Butler W. T. Structural and functional domains of osteopontin. Ann N Y Acad Sci. 1995 Apr 21;760:6–11. doi: 10.1111/j.1749-6632.1995.tb44615.x. [DOI] [PubMed] [Google Scholar]
  7. Chen Y., Bal B. S., Gorski J. P. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem. 1992 Dec 5;267(34):24871–24878. [PubMed] [Google Scholar]
  8. Clore J. N., Cohen I. K., Diegelmann R. F. Quantitation of collagen types I and III during wound healing in rat skin. Proc Soc Exp Biol Med. 1979 Jul;161(3):337–340. doi: 10.3181/00379727-161-40548. [DOI] [PubMed] [Google Scholar]
  9. Craig A. M., Denhardt D. T. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene. 1991 Apr;100:163–171. doi: 10.1016/0378-1119(91)90362-f. [DOI] [PubMed] [Google Scholar]
  10. Danielson K. G., Baribault H., Holmes D. F., Graham H., Kadler K. E., Iozzo R. V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997 Feb 10;136(3):729–743. doi: 10.1083/jcb.136.3.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davisson M. T. Genetic nomenclature guide. Mouse. Trends Genet. 1995 Mar;:35–38. [PubMed] [Google Scholar]
  12. Denhardt D. T., Lopez C. A., Rollo E. E., Hwang S. M., An X. R., Walther S. E. Osteopontin-induced modifications of cellular functions. Ann N Y Acad Sci. 1995 Apr 21;760:127–142. doi: 10.1111/j.1749-6632.1995.tb44625.x. [DOI] [PubMed] [Google Scholar]
  13. Fan C. M., Tessier-Lavigne M. Patterning of mammalian somites by surface ectoderm and notochord: evidence for sclerotome induction by a hedgehog homolog. Cell. 1994 Dec 30;79(7):1175–1186. doi: 10.1016/0092-8674(94)90009-4. [DOI] [PubMed] [Google Scholar]
  14. Fet V., Dickinson M. E., Hogan B. L. Localization of the mouse gene for secreted phosphoprotein 1 (Spp-1) (2ar, osteopontin, bone sialoprotein 1, 44-kDa bone phosphoprotein, tumor-secreted phosphoprotein) to chromosome 5, closely linked to Ric (Rickettsia resistance). Genomics. 1989 Aug;5(2):375–377. doi: 10.1016/0888-7543(89)90074-8. [DOI] [PubMed] [Google Scholar]
  15. Franzén A., Heinegård D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J. 1985 Dec 15;232(3):715–724. doi: 10.1042/bj2320715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Giachelli C. M., Pichler R., Lombardi D., Denhardt D. T., Alpers C. E., Schwartz S. M., Johnson R. J. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994 Feb;45(2):515–524. doi: 10.1038/ki.1994.67. [DOI] [PubMed] [Google Scholar]
  17. Hynes R. O. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol. 1996 Dec 15;180(2):402–412. doi: 10.1006/dbio.1996.0314. [DOI] [PubMed] [Google Scholar]
  18. Iozzo R. V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 1997;32(2):141–174. doi: 10.3109/10409239709108551. [DOI] [PubMed] [Google Scholar]
  19. Lampe M. A., Patarca R., Iregui M. V., Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol. 1991 Nov 1;147(9):2902–2906. [PubMed] [Google Scholar]
  20. Leibovich S. J., Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975 Jan;78(1):71–100. [PMC free article] [PubMed] [Google Scholar]
  21. Liaw L., Almeida M., Hart C. E., Schwartz S. M., Giachelli C. M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994 Feb;74(2):214–224. doi: 10.1161/01.res.74.2.214. [DOI] [PubMed] [Google Scholar]
  22. Liaw L., Skinner M. P., Raines E. W., Ross R., Cheresh D. A., Schwartz S. M., Giachelli C. M. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995 Feb;95(2):713–724. doi: 10.1172/JCI117718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liu X., Wu H., Byrne M., Krane S., Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1852–1856. doi: 10.1073/pnas.94.5.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McKee M. D., Nanci A. Secretion of Osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis. Anat Rec. 1996 Jun;245(2):394–409. doi: 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  25. McKee M. D., Zalzal S., Nanci A. Extracellular matrix in tooth cementum and mantle dentin: localization of osteopontin and other noncollagenous proteins, plasma proteins, and glycoconjugates by electron microscopy. Anat Rec. 1996 Jun;245(2):293–312. doi: 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  26. Mukherjee B. B., Nemir M., Beninati S., Cordella-Miele E., Singh K., Chackalaparampil I., Shanmugam V., DeVouge M. W., Mukherjee A. B. Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann N Y Acad Sci. 1995 Apr 21;760:201–212. doi: 10.1111/j.1749-6632.1995.tb44631.x. [DOI] [PubMed] [Google Scholar]
  27. Murry C. E., Giachelli C. M., Schwartz S. M., Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994 Dec;145(6):1450–1462. [PMC free article] [PubMed] [Google Scholar]
  28. Nomura S., Wills A. J., Edwards D. R., Heath J. K., Hogan B. L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol. 1988 Feb;106(2):441–450. doi: 10.1083/jcb.106.2.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Noorman F., Braat E. A., Barrett-Bergshoeff M., Barbé E., van Leeuwen A., Lindeman J., Rijken D. C. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol. 1997 Jan;61(1):63–72. doi: 10.1002/jlb.61.1.63. [DOI] [PubMed] [Google Scholar]
  30. Okada A., Tomasetto C., Lutz Y., Bellocq J. P., Rio M. C., Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol. 1997 Apr 7;137(1):67–77. doi: 10.1083/jcb.137.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oldberg A., Franzén A., Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819–8823. doi: 10.1073/pnas.83.23.8819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Patarca R., Freeman G. J., Singh R. P., Wei F. Y., Durfee T., Blattner F., Regnier D. C., Kozak C. A., Mock B. A., Morse H. C., 3rd Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med. 1989 Jul 1;170(1):145–161. doi: 10.1084/jem.170.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Portera C. A., Love E. J., Memore L., Zhang L., Müller A., Browder W., Williams D. L. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg. 1997 Feb;63(2):125–131. [PubMed] [Google Scholar]
  34. Rowe L. B., Nadeau J. H., Turner R., Frankel W. N., Letts V. A., Eppig J. T., Ko M. S., Thurston S. J., Birkenmeier E. H. Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm Genome. 1994 May;5(5):253–274. doi: 10.1007/BF00389540. [DOI] [PubMed] [Google Scholar]
  35. Segre J. A., Nemhauser J. L., Taylor B. A., Nadeau J. H., Lander E. S. Positional cloning of the nude locus: genetic, physical, and transcription maps of the region and mutations in the mouse and rat. Genomics. 1995 Aug 10;28(3):549–559. doi: 10.1006/geno.1995.1187. [DOI] [PubMed] [Google Scholar]
  36. Senger D. R., Wirth D. F., Hynes R. O. Transformation-specific secreted phosophoproteins. Nature. 1980 Aug 7;286(5773):619–621. doi: 10.1038/286619a0. [DOI] [PubMed] [Google Scholar]
  37. Shepherd V. L., Abdolrasulnia R., Garrett M., Cowan H. B. Down-regulation of mannose receptor activity in macrophages after treatment with lipopolysaccharide and phorbol esters. J Immunol. 1990 Sep 1;145(5):1530–1536. [PubMed] [Google Scholar]
  38. Singh R. P., Patarca R., Schwartz J., Singh P., Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med. 1990 Jun 1;171(6):1931–1942. doi: 10.1084/jem.171.6.1931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Smith J. H., Denhardt D. T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem. 1987 May;34(1):13–22. doi: 10.1002/jcb.240340103. [DOI] [PubMed] [Google Scholar]
  40. Thayer J. M., Giachelli C. M., Mirkes P. E., Schwartz S. M. Expression of osteopontin in the head process late in gastrulation in the rat. J Exp Zool. 1995 Jun 15;272(3):240–244. doi: 10.1002/jez.1402720309. [DOI] [PubMed] [Google Scholar]
  41. Tybulewicz V. L., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991 Jun 28;65(7):1153–1163. doi: 10.1016/0092-8674(91)90011-m. [DOI] [PubMed] [Google Scholar]
  42. Weber G. F., Cantor H. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev. 1996 Oct;7(3):241–248. doi: 10.1016/s1359-6101(96)00030-5. [DOI] [PubMed] [Google Scholar]
  43. Zhao G. Q., Deng K., Labosky P. A., Liaw L., Hogan B. L. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev. 1996 Jul 1;10(13):1657–1669. doi: 10.1101/gad.10.13.1657. [DOI] [PubMed] [Google Scholar]
  44. Zhao G. Q., Hogan B. L. Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development. Mech Dev. 1996 Jul;57(2):159–168. doi: 10.1016/0925-4773(96)00543-6. [DOI] [PubMed] [Google Scholar]
  45. Zheng X., Saunders T. L., Camper S. A., Samuelson L. C., Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12426–12430. doi: 10.1073/pnas.92.26.12426. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES